Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model

Blood

Volumn 105, Issue 1, 2005, Pages 420-425

  Anderson, Stasia A ^a   Glod, John ^b   Arbab, Ali S ^b   Noel, Martha ^b   Ashari, Parwana ^b   Fine, Howard A ^b   Frank, Joseph A ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CONTRAST MEDIUM; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BRAIN TUMOR; CELL LABELING; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; GENE THERAPY; GENE VECTOR; GLIOMA; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MAGNETISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STEM CELL; TUMOR GROWTH;

EID: 11144247257     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-06-2222     Document Type: Article

References (23)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
2. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
3. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-228.
4. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone marrow-derived hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001;7:1194-1201.
5. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702-712.
6. Ferrari N, Glod J, Lee J, Kobiler D, Fine HF. Bone marrow-derived endothelial progenitor-like cells as angiogenesis-selective gene targeting vectors. Gene Ther. 2003;10:647-656.
7. DePalma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med. 2003;9:789-795.
8. Frank JA, Zywicke H, Jordan EK, et al. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol. 2002;9:S484-S488.
9. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian cells and stem cells by combining (FDA)-approved superparamagnetic iron oxides and commonly available transfection agents. Radiology. 2003;228:480-487.
10. Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles (Ferumoxides) and transfection agent (poly-l-lysine) for cellular MR imaging. Radiology. 2003;229:838-846.
11. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JWM, Frank JA. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation. 2003;76:1123-1130.
12. Bulte JWM, Zhang SC, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocytes progenitors: MR tracking of cell migration and myelination. Proc Natl Acad Sci U S A. 1999;96:15256-15261.
13. Bulte JWM, Douglas T, Witer B, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol. 2001;19:1141-1147.
14. Anderson SA, Shukaliak-Quandt J, Jordan EK, et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol. 2004;55:654-659.
15. Arbab AS, Yocum GT, Wilson LB, et al. Comparison of transfection agents in forming complexes with Ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging. 2004;3:24-32.
16. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med. 2003;9: 713-725.
17. Costuros NG, Diehn FE, Libutti SK. Molecular imaging of angiogenesis. J Cell Biochem Suppl. 2002;39:72-78.
18. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003;17:509-520.
19. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223:11-29.
20. Zagzag D, Amirnovin R, Greco A, et al. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest. 2000;80: 837-849.
21. Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med. 2003;49:848-855.
22. Moore X-L, Lu J, Sun L, et al. Endothelial progenitor cells' 'homing' specificity to brain tumors. Gene Ther. 2004;11:811-818.
23. Arbab AS, Yocum GT, Kalish H, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood. 2004;104:1217-1223.